{"id":1696,"date":"2021-12-20T19:16:51","date_gmt":"2021-12-20T13:46:51","guid":{"rendered":"https:\/\/www.fitterfly.com\/blog\/?p=1696"},"modified":"2024-06-12T16:17:11","modified_gmt":"2024-06-12T10:47:11","slug":"powerful-partnerships-doctors-team-up-with-dtx-companies-across-the-world","status":"publish","type":"post","link":"https:\/\/www.fitterfly.com\/blog\/powerful-partnerships-doctors-team-up-with-dtx-companies-across-the-world\/","title":{"rendered":"Powerful Partnerships! Doctors Team Up With Digital Therapeutics Companies Across the World"},"content":{"rendered":"<p><i><span style=\"font-weight: 400;\">Is it an app?<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">Is it software?<\/span><\/i><\/p>\n<p><i><span style=\"font-weight: 400;\">Is it a service?<\/span><\/i><\/p>\n<p>In this article you will read about:<\/p>\n<ul>\n<li><strong><a href=\"#one\">No, it\u2019s Digital Therapeutics! <\/a><\/strong><\/li>\n<li><strong><a href=\"#two\">Why is Digital Therapeutics poised to flourish?<\/a><\/strong><\/li>\n<li><strong><a href=\"#three\">Read on as we bust 5 Myths about Digital Therapeutics! <\/a><\/strong><\/li>\n<\/ul>\n<h2><b><span id=\"one\">No, it\u2019s Digital Therapeutics!<\/span><\/b><\/h2>\n<p><span style=\"font-weight: 400;\">Digital Therapeutics (DTx) may be a relatively new model of healthcare services in India, but there are already thousands of health and fitness applications in the market, that claim to provide great outcomes for patients. However, how many of them have outcomes that are<\/span><b><i> clinically validated?\u00a0<\/i><\/b><\/p>\n<p><span style=\"font-weight: 400;\">A DTx platform is a product that is software-driven, evidence-based and aims to prevent, manage, or treat a medical disease.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">According to the\u00a0 <\/span><a href=\"https:\/\/dtxalliance.org\/understanding-dtx\/\"><span style=\"font-weight: 400;\">DTx Alliance,<\/span><\/a><span style=\"font-weight: 400;\"> these interventions can be used independently or combined with medications, devices, or other therapies, with the goal of optimizing outcomes for our patients.\u00a0<\/span><\/p>\n<h2><b><span id=\"two\">Why is Digital Therapeutics poised to flourish?<\/span><\/b><\/h2>\n<p><span style=\"font-weight: 400;\">It\u2019s all about \u2013 Access, Convenience, and Efficacy!<\/span><\/p>\n<ol>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">As a digital service, DTx platforms can collect and analyze data, provide recommendations and<\/span><b> interact <\/b><span style=\"font-weight: 400;\">with both healthcare providers and their patients.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">It provides services that are scalable, so we deliver better care, with fewer resources<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">It can extend the physicians\u2019 reach by overcoming time, place, and personnel constraints that limit healthcare delivery.<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">It can alleviate the hidden costs of managing a chronic illness like traveling to clinics or care centers or the loss of pay of the caregivers. DTx can offer them extended care from the comfort of their own homes, which boosts patient compliance to treatments as well.<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\">We can leverage the power of face-to-face interactions with medical professionals but make them accessible to a larger population, thereby affecting patient behavioral change <span style=\"font-weight: 400;\">on a large scale.\u00a0<\/span><\/li>\n<\/ol>\n<p><span style=\"font-weight: 400;\">The buzz around digital therapeutics is growing, as medical communities worldwide, are rapidly adopting these solutions in their practices. In India, we are making great headways in the implementation of DTx in routine practice, but there are some common misconceptions that need to be addressed.\u00a0<\/span><\/p>\n<h2><b><i><span id=\"three\">Read on as we bust 5 Myths about Digital Therapeutics!<\/span><\/i><\/b><b><\/b><\/h2>\n<h3><b>1. Myth: DTx is a very recent innovation.<\/b><\/h3>\n<p><b>Fact<\/b><span style=\"font-weight: 400;\">: <\/span><span style=\"font-weight: 400;\">The concept of using digital methods to deliver healthcare interventions has been around since the early 2000s. The term \u201cdigital therapeutics\u201d created waves <\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25863515\/\"><span style=\"font-weight: 400;\">in 2015, <\/span><\/a><span style=\"font-weight: 400;\">and the field has grown considerably since then.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Trailblazers in the DTx Space include<\/span> <b>Omada Health<\/b><span style=\"font-weight: 400;\"> in San Francisco, California, which is recognized by the CDC and has met the evidence-based standards of the<\/span><a href=\"https:\/\/medcitynews.com\/2015\/03\/omada\/#:~:text=evidence%2Dbased%20standards%20of%20the%20National%20Diabetes%20Prevention%20Program.\"> <span style=\"font-weight: 400;\">National diabetes prevention program<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Another popular platform,<\/span><b> Livongo <\/b><span style=\"font-weight: 400;\">is a pioneer in Applied Health Signals, translating data into actionable and timely signals. They partnered with Amazon, Apple, Samsung, and Fitbit to apply their health data to various customer interfaces.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">They also published a retrospective analysis of 10,000 patients in the\u00a0 <\/span><a href=\"https:\/\/www.prnewswire.com\/news-releases\/study-in-journal-of-medical-economics-reveals-reduced-medical-spending-with-the-livongo-for-diabetes-program-300846951.html\"><span style=\"font-weight: 400;\">Journal of Medical Economics<\/span><\/a><span style=\"font-weight: 400;\"> when working with pharma giant Eli Lilly, which revealed that <\/span><span style=\"font-weight: 400;\">Livongo&#8217;s <a href=\"https:\/\/www.fitterfly.com\/blog\/diabefly-the-best-diabetes-management-program-to-prevent-reverse-or-manage-diabetes\/\" target=\"_blank\" rel=\"noopener\">diabetes program<\/a> can prevent $88 worth of medical spending per person per month. <\/span><\/p>\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5527250\/\"><span style=\"font-weight: 400;\">Another study<\/span><\/a><span style=\"font-weight: 400;\"> evaluated Livongo members who experienced an average 18.4% decrease in hypoglycemia and an average 16.4% decrease in hyperglycemia in months 2-12 compared with the first month as the baseline.\u00a0<\/span><\/p>\n<h3><b><\/b><b>2. Myth: DTx works only for chronic, metabolic conditions.<\/b><\/h3>\n<p><b>Fact:<\/b> <span style=\"font-weight: 400;\">Although the most common applications are in lifestyle diseases like diabetes and heart health, their applications can also be seen in various other conditions, like obesity, Alzheimer&#8217;s disease, dementia, asthma, substance abuse, ADHD, hypertension, anxiety, depression, or burnout.\u00a0<\/span><b><\/b><\/p>\n<h3><b>3. Myth: Dtx is still at an experimental stage<\/b><\/h3>\n<p><b>Fact:<\/b> <span style=\"font-weight: 400;\">The<\/span><a href=\"https:\/\/health.economictimes.indiatimes.com\/news\/health-it\/digital-therapeutics-revolutionizing-the-virtual-healthcare-industry\/86170153\"> <span style=\"font-weight: 400;\">value of the global DTx<\/span><\/a><span style=\"font-weight: 400;\"> market is estimated at USD 1.8 billion in 2018, which is expected to reach USD 7.1 billion by 2025. This points to major investments made globally and indicates the promise of growth in Dtx.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In fact, in countries like the United States, insurers are reimbursing patient claims based on digital therapeutics. This mirrors the overall positive <\/span><span style=\"font-weight: 400;\">global outlook on digital health.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In a study conducted by <\/span><a href=\"https:\/\/clarivate.com\/lp\/u-s-payers-warming-covering-digital-therapeutics\/\"><span style=\"font-weight: 400;\">insurance giant Clarivate, <\/span><\/a><span style=\"font-weight: 400;\">it was revealed that 25% of their partner healthcare organizations currently provide coverage for DTx, while another 45% expressed interest in providing coverage soon. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">US\u2019 Medicare announced that healthcare providers would be able to bill for remote health visits in the same way as in-person visits during the pandemic.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In Europe, the EU\u2019s existing digitalization agenda (Digital Europe)<\/span> <span style=\"font-weight: 400;\">has been reinforced with a stronger focus on health and healthcare, with the EU set to invest \u20ac5.3bn through <\/span><span style=\"font-weight: 400;\">EU4Health,<\/span> <span style=\"font-weight: 400;\">while in the UK, the recently created<\/span><a href=\"https:\/\/www.nhsx.nhs.uk\/\"> <span style=\"font-weight: 400;\">NHSX<\/span> <span style=\"font-weight: 400;\">aims<\/span><\/a><span style=\"font-weight: 400;\"> to be, a bridge between healthcare and technology.<\/span><b><\/b><\/p>\n<h3><b>4. Myth: Patient data is unsafe with DTx companies<\/b><\/h3>\n<p><b>Fact &#8211;<\/b><span style=\"font-weight: 400;\">\u00a0 Dtx platforms have regulatory requirements to protect their patient\u2019s data. They undertake proactive measures like:\u00a0<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Restricting access to data and its applications<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Implementing data usage controls<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Encrypting data<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Securing mobile devices<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Conducting regular risk assessments<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Utilizing off-site data backup<\/span><\/li>\n<\/ul>\n<h3><b>5. Myth: DTx is not regulated<\/b><\/h3>\n<p><b>Fact:<\/b><span style=\"font-weight: 400;\"> India has made tremendous progress in defining regulations for the application of digital health in recent years. The introduction of<\/span><a href=\"https:\/\/www.nhp.gov.in\/NHPfiles\/National_Digital_Health_Blueprint_Report_comments_invited.pdf\"> <span style=\"font-weight: 400;\">the National Digital Health Blueprint<\/span><\/a><span style=\"font-weight: 400;\"> and the guidelines for<\/span><a href=\"https:\/\/main.mohfw.gov.in\/sites\/default\/files\/20%20ChapterAN2018-19.pdf\"><span style=\"font-weight: 400;\"> telemedicine<\/span><\/a><span style=\"font-weight: 400;\"> in 2020, provided regulatory approval from the authorities and defined standards among various stakeholders.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">However, we still have a long way to go.<\/span><\/p>\n<p><i><span style=\"font-weight: 400;\">At Fitterfly, we recognize the challenge of validating DTx and we are so pleased that our efforts to do so, through peer-reviewed papers and presentations, led to great results over the last few years. Our clinical trials provide supporting evidence of the safety and efficacy of DTx in the Indian context.\u00a0<\/span><\/i><\/p>\n<p><span style=\"font-weight: 400;\">Papers and research conducted by Fitterfly &#8211; <\/span><a href=\"https:\/\/www.fitterfly.com\/research\/list\"><span style=\"font-weight: 400;\">https:\/\/www.fitterfly.com\/research\/list<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Diabefly outcomes presented at:<\/span><br \/>\n<b><\/b><\/p>\n<ol>\n<li><b>International Diabetes Federation (IDF-2021)<\/b><\/li>\n<li><b>RSSDI &#8211; 2021<\/b><\/li>\n<li><b>Diabetes Therapy, 2021<\/b><\/li>\n<li><strong>AACE 2020<\/strong><\/li>\n<li><b>ESICON-2021<\/b><\/li>\n<li><b>US ENDO 2021<\/b><\/li>\n<li><b>ESI 2020<\/b><\/li>\n<li><b>Chellaram International Diabetes Summit 2020<\/b><\/li>\n<li><b><b><b>IDACON 2019<\/b><\/b><\/b><\/li>\n<\/ol>\n<p><b><b><br \/>\n<span style=\"font-weight: 400;\">Considering how fast the <a href=\"https:\/\/www.fitterfly.com\/blog\/10-ways-in-which-digital-therapeutics-helps-doctors-in-their-day-to-day-practice\/\" target=\"_blank\" rel=\"noopener\">field of Digital Therapeutics is growing<\/a>, and the myriad of opportunities it offers, we invite you to find out more about our product and services for your patients. <\/span><\/b><\/b><\/p>\n<p><b><b><span style=\"font-weight: 400;\">We would also welcome the opportunity to collaborate with you in conducting your own research, as you use our platform. <\/span><span style=\"font-weight: 400;\">Please feel free to reach out to us through the details given below.\u00a0<\/span><\/b><\/b><\/p>\n<p><span style=\"font-weight: 400;\">Phone: 9769240096\/ 7702699722<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Email: <\/span><a href=\"mailto:doctors@fittefly.in\"><span style=\"font-weight: 400;\">doctors@fitterfly.in<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Is it an app? Is it software? Is it a service? In this article you will read about: No, it\u2019s Digital Therapeutics! Why is Digital Therapeutics poised to flourish? Read [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":1697,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"wds_primary_category":0,"footnotes":""},"categories":[412,410],"tags":[],"acf":{"reviewed_by":false,"references":null,"author":"","table_content":null,"medically_reviewed":"Not Selected","show_updated_date_in_post":"No","faq_list":null,"custom_schema":"","media_url":"","reviewer":null},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/posts\/1696"}],"collection":[{"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/comments?post=1696"}],"version-history":[{"count":0,"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/posts\/1696\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/media\/1697"}],"wp:attachment":[{"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/media?parent=1696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/categories?post=1696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fitterfly.com\/blog\/wp-json\/wp\/v2\/tags?post=1696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}